HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers.
Saved in:
| Title: | HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers. |
|---|---|
| Authors: | El-Botty R; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Vacher S; Department of Genetics, Institut Curie, PSL Research University, Paris, France., Mainguené J; Department of Genetics, Institut Curie, PSL Research University, Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France., Briaux A; Department of Genetics, Institut Curie, PSL Research University, Paris, France., Ibadioune S; Department of Genetics, Institut Curie, PSL Research University, Paris, France., Dahmani A; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Montaudon E; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Nemati F; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Huguet L; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Sourd L; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Morriset L; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Château-Joubert S; BioPole Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons Alfort, France., Dubois T; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Maire V; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Lidereau R; Department of Genetics, Institut Curie, PSL Research University, Paris, France., Rapinat A; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Gentien D; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Coussy F; Department of Genetics, Institut Curie, PSL Research University, Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France., Bièche I; Department of Genetics, Institut Curie, PSL Research University, Paris, France.; Faculty of Pharmaceutical and Biological Sciences, Paris City University, Inserm U1016, France., Marangoni E; Translational Research Department, Institut Curie, PSL Research University, Paris, France. |
| Source: | Molecular oncology [Mol Oncol] 2023 Oct; Vol. 17 (10), pp. 2017-2028. Date of Electronic Publication: 2023 Mar 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36852691 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22El-Botty+R%22">El-Botty R</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vacher+S%22">Vacher S</searchLink>; Department of Genetics, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mainguené+J%22">Mainguené J</searchLink>; Department of Genetics, Institut Curie, PSL Research University, Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Briaux+A%22">Briaux A</searchLink>; Department of Genetics, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ibadioune+S%22">Ibadioune S</searchLink>; Department of Genetics, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dahmani+A%22">Dahmani A</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Montaudon+E%22">Montaudon E</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nemati+F%22">Nemati F</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Huguet+L%22">Huguet L</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sourd+L%22">Sourd L</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Morriset+L%22">Morriset L</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Château-Joubert+S%22">Château-Joubert S</searchLink>; BioPole Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons Alfort, France.<br /><searchLink fieldCode="AU" term="%22Dubois+T%22">Dubois T</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Maire+V%22">Maire V</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lidereau+R%22">Lidereau R</searchLink>; Department of Genetics, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rapinat+A%22">Rapinat A</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gentien+D%22">Gentien D</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Coussy+F%22">Coussy F</searchLink>; Department of Genetics, Institut Curie, PSL Research University, Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bièche+I%22">Bièche I</searchLink>; Department of Genetics, Institut Curie, PSL Research University, Paris, France.; Faculty of Pharmaceutical and Biological Sciences, Paris City University, Inserm U1016, France.<br /><searchLink fieldCode="AU" term="%22Marangoni+E%22">Marangoni E</searchLink>; Translational Research Department, Institut Curie, PSL Research University, Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2023 Oct; Vol. 17 (10), pp. 2017-2028. <i>Date of Electronic Publication: </i>2023 Mar 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36852691 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1878-0261.13412 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2017 Titles: – TitleFull: HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: El-Botty R – PersonEntity: Name: NameFull: Vacher S – PersonEntity: Name: NameFull: Mainguené J – PersonEntity: Name: NameFull: Briaux A – PersonEntity: Name: NameFull: Ibadioune S – PersonEntity: Name: NameFull: Dahmani A – PersonEntity: Name: NameFull: Montaudon E – PersonEntity: Name: NameFull: Nemati F – PersonEntity: Name: NameFull: Huguet L – PersonEntity: Name: NameFull: Sourd L – PersonEntity: Name: NameFull: Morriset L – PersonEntity: Name: NameFull: Château-Joubert S – PersonEntity: Name: NameFull: Dubois T – PersonEntity: Name: NameFull: Maire V – PersonEntity: Name: NameFull: Lidereau R – PersonEntity: Name: NameFull: Rapinat A – PersonEntity: Name: NameFull: Gentien D – PersonEntity: Name: NameFull: Coussy F – PersonEntity: Name: NameFull: Bièche I – PersonEntity: Name: NameFull: Marangoni E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2023 Oct Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1878-0261 Numbering: – Type: volume Value: 17 – Type: issue Value: 10 Titles: – TitleFull: Molecular oncology Type: main |
| ResultId | 1 |